<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101697847</journal-id>
<journal-id journal-id-type="pubmed-jr-id">46024</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Opin Toxicol</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Opin Toxicol</journal-id>
<journal-title-group>
<journal-title>Current opinion in toxicology</journal-title>
</journal-title-group>
<issn pub-type="ppub">2468-2934</issn>
<issn pub-type="epub">2468-2020</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31602419</article-id>
<article-id pub-id-type="pmc">6785977</article-id>
<article-id pub-id-type="doi">10.1016/j.cotox.2018.12.007</article-id>
<article-id pub-id-type="manuscript">NIHMS1519448</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Toxicant-mediated redox control of proteostasis in neurodegeneration</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Aivazidis</surname>
<given-names>Stefanos</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Anderson</surname>
<given-names>Colin C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roede</surname>
<given-names>James R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Pharmaceutical Sciences, Skaggs School of
Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical
Campus, Aurora, CO 80045.</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Corresponding author, James R. Roede, 12850 E.
Montview Blvd., C238, V20-2123, Aurora, CO 80045, (p) 303-724-1348, (f)
303-724-7266</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2020</year>
</pub-date>
<volume>13</volume>
<fpage>22</fpage>
<lpage>34</lpage>
<!--elocation-id from pubmed: 10.1016/j.cotox.2018.12.007-->
<self-uri xlink:href="https://www.sciencedirect.com/science/article/pii/S2468202018300391?via%3Dihub"></self-uri>
<abstract id="ABS1">
<p id="P1">Disruption in redox signaling and control of cellular processes has
emerged as a key player in many pathologies including neurodegeneration. As
protein aggregations are a common hallmark of several neuronal pathologies, a
firm understanding of the interplay between redox signaling, oxidative and free
radical stress, and proteinopathies is required to sort out the complex
mechanisms in these diseases. Fortunately, models of toxicant-induced
neurodegeneration can be utilized to evaluate and report mechanistic alterations
in the proteostasis network (PN). The epidemiological links between
environmental toxicants and neurological disease gives further credence into
characterizing the toxicant-mediated PN disruptions observed in these
conditions. Reviewed here are examples of mechanistic interaction between
oxidative or free radical stress and PN alterations. Additionally,
investigations into toxicant-mediated PN disruptions, specifically focusing on
environmental metals and pesticides, are discussed. Finally, we emphasize the
need to distinguish whether the presence of protein aggregations are
contributory to phenotypes related to neurodegeneration, or if they are a
byproduct of PN deficiencies.</p>
</abstract>
<kwd-group>
<kwd>Neurodegeneration</kwd>
<kwd>Proteostasis Network</kwd>
<kwd>Protein Aggregation</kwd>
<kwd>Environmental Toxicants</kwd>
<kwd>Redox Proteome</kwd>
<kwd>Oxidative Stress</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>